Clinical Trial Update: Clofarabine and Ara-C for the Treatment of Relapsed AML and Untreated MDS [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the combination of clofarabine and cytarabine (Ara-C) for relapsed acute myeloid leukemia and untreated myelodysplastic syndro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Clofarabine (Clolar) (clofarabine)
• Cytarabine (Ara-C) (cytarabine)

Snippet

Sponsor: Baylor Research Institute | Conditions: Acute Myelogenous Leukemia, Myelodysplastic Syndromes | Phase 2 | Status: COMPLETED | Results posted: 2013-07-17